Podcasts about Colon

Why are we still treating acute uncomplicated diverticulitis with antibiotics? There is plenty of evidence from several randomized controlled trials demonstrating that symptomatic management alone yields similar results. If we should continue prescribing antibiotics for acute uncomplicated diverticulitis, which patients should undergo treatment and when? Join Drs. Jared Hendren, Elissa Dabaghi, Joseph Trunzo, Ajaratu Keshinro, and David Rosen as they discuss the management of uncomplicated diverticulitis while reviewing groundbreaking literature. Hosts: -Jared Hendren, MD Institution: Department of General Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio - Elissa Dabaghi, MD Institution: Department of General Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio - Joseph Trunzo, MD Institution: Department of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio Social Media Handle: X/Twitter @joseph_trunzo - Ajaratu Keshinro, MD Institution: Department of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio Social Media Handle: X/Twitter- @AJKesh - David Rosen, MD Institution: Department of Colon and Rectal Surgery, Digestive Disease Institute, Cleveland Clinic Foundation, Cleveland, Ohio Social Media Handle: X/Twitter- @davidrrosenmd Learning Objectives: By the end of this episode, listeners will be able to: 1.     Identify criteria for managing acute uncomplicated diverticulitis without antibiotics based on recent literature 2.     Define uncomplicated and complicated diverticulitis 3.     Discuss nuanced management decisions of patients with uncomplicated diverticulitis to determine when antibiotics may be appropriate for management References: 1.     Azhar, N., Aref, H., Brorsson, A., Lydrup, M.‑L., Jörgren, F., Schultz, J. K., & Buchwald, P. (2022). Management of acute uncomplicated diverticulitis without antibiotics: Compliance and outcomes – a retrospective cohort study. BMC Emergency Medicine, 22(1), Article 28. https://doi.org/10.1186/s12873‑022‑00584‑X  2.     Mora‑López, L., Ruiz‑Edo, N., Estrada‑Ferrer, O., Piñana‑Campón, M. L., Labró‑Ciurans, M., Escuder‑Perez, J., Sales‑Mallafré, R., Rebasa‑Cladera, P., Navarro‑Soto, S., Serra‑Aracil, X., & DINAMO‑study Group. (2021). Efficacy and safety of nonantibiotic outpatient treatment in mild acute diverticulitis (DINAMO‑study): A multicentre, randomised, open‑label, noninferiority trial. Annals of Surgery, 274(5), e435–e442. https://doi.org/10.1097/SLA.0000000000005031 3.     Daniels, L., Ünlü, Ç., de Korte, N., van Dieren, S., Stockmann, H. B., Vrouenraets, B. C., Consten, E. C., van der Hoeven, J. A., Eijsbouts, Q. A., Faneyte, I. F., Bemelman, W. A., Dijkgraaf, M. G., & Boermeester, M. A. (2017). Randomized clinical trial of observational versus antibiotic treatment for a first episode of CT‑proven uncomplicated acute diverticulitis. British Journal of Surgery, 104(1), 52‑61. https://doi.org/10.1002/bjs.10309 4.     Chabok, A., Påhlman, L., Hjern, F., Haapaniemi, S., & Smedh, K.; AVOD Study Group. (2012). Randomized clinical trial of antibiotics in acute uncomplicated diverticulitis. British Journal of Surgery, 99(4), 532–539. https://doi.org/10.1002/bjs.8688 Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

Welcome back to our weekend Cabral HouseCall shows! This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track! Check out today's questions:    Leah: Hi, I was wondering if you know about how to deal with constipation and stuck poop due to tortuous colon. Thank you!                                                                                                                                                                                 Bettina: Dear Dr. Cabral, I'm reaching out regarding my husband, who is 47 years old and experiencing a range of symptoms that we're hoping to better understand. He has sensitive gums that are gradually receding, and he produces an excessive amount of earwax. He blows his nose daily and often feels tightness and tension in his neck, throat, and upper body. He is gluten intolerant and also reacts to milk sugar and lactose. Additionally, he frequently struggles to fall asleep. While these symptoms may not be directly related, I'd greatly appreciate your insight into any potential underlying connections or contributing factors and ideas to what my husband can do to change this. Thank you very much for your time and expertise.                                                                                                                                                                        Ellen: I have a question about high serum vitamin B12 levels. The normal range on the lab is 232 - 946. I am more than double the high end of the range at 1945. I take a daily multivitamin with with 400 mcg of B12, and take no other B12 supplement. Why is my number so high?                                                                                           Diana: Hi Dr. Cabral, My liver is stressed. Found out I have fatty liver in May, but am already doing everything I should to help reverse it. I'm wondering what you would do in my situation. For background, I have Ehlers Danlos & ME/CFS for 30 years (I'm 42). Have horrible PEM (can't walk for 5 mins, have to carefully plan all exertion), so can't exercise. Hypometabolic & blood glucose constantly elevated & spikes with exertion (walking to my kitchen, etc.), but eat healthy & no spikes with food. EBV reactivated 5 years ago & won't go away. Did Big 5 last year, nothing with liver came up. Have mold toxicity & SIBO, took binders to help. Did CBO protocol, but SIBO & mold won't go away. Do 21-day detox regularly, take DNS powder 2x per day + almost all supplements suggested in NAFLD podcast.                                                                                                   Allen: I am new to your podcast but saw you are offering the First Labs Program for 50% off labs. Is this all labs like the Big 5, or only certain ones. Can I run all of them? Thanks for all your help and work you are putting out!     Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!    - - - Show Notes and Resources: StephenCabral.com/3508 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!    

Study Discovers Increased Cancers After MRNA Vaccines, Bret Weinstein- Covid & mRNA: Harms and Damages Exposed Bret Weinstein- Covid & mRNA: Harms and Damages Exposed (NEW!) REMINDER: CDC Didn't Track VAERS Safety Signals John Campbell- Increased cancers after mRNA vaccines   Study- Covid & mRNA: Harms and Damages Exposed (NEW!) | DarkHorse https://youtu.be/zkrbZmYuRoY?si=_0yO0y5ftLacoVJ1 Bret Weinstein 512K subscribers 25,699 views Sep 5, 2025 A new article on the harms and hazards of both SARS-CoV2 and the mRNA biologics said to counter the virus. Full Episode: https://youtube.com/live/wQWkKrM3Dt8 Mentioned in this segment: Zywiec et al 2025. COVID-19 Injections: Harms and Damages, a Non-Exhaustive Conclusion. Journal of American Physicians and Surgeons, 30(3): https://jpands.org/vol30no3/zywiec.pdf ***** Join us on Locals! Get access to our Discord server, exclusive live streams, live chats for all streams, and early access to many podcasts: https://darkhorse.locals.com Heather's newsletter, Natural Selections (subscribe to get free weekly essays in your inbox): https://naturalselections.substack.com Our book, A Hunter-Gatherer's Guide to the 21st Century, is available everywhere books are sold, including from Amazon: https://amzn.to/3AGANGg (commission earned) Check out our store! Epic tabby, digital book burning, saddle up the dire wolves, and more: https://darkhorsestore.org   REMINDER: CDC Didn't Track VAERS Safety Signals | DarkHorse https://youtu.be/u3UAyr6s7xc?si=VUoenskCyMdViArS Bret Weinstein 512K subscribers 16,906 views Sep 5, 2025 RFK Jr. fires the new director, after which other CDC officials resign, and eight former directors of the CDC pen a letter to the New York Times arguing that Kennedy is a hazard to our health. Bret Weinstein and Heather Heying discuss "The Plot Against Kennedy" in Episode 292 of The Evolutionary Lens. Full Episode: https://youtube.com/live/wQWkKrM3Dt8 Mentioned in this segment: NYT op-ed #2 from former CDC directors: We Ran the C.D.C.: Kennedy Is Endangering Every American's Health: https://www.nytimes.com/2025/09/01/op... Bret and Heather 132nd DarkHorse Podcast Livestream: 50 States not in a Roe https://youtube.com/live/usP2D_qGUZs CDC didn't monitor VAERS for COVID safety signals (June 2022): https://childrenshealthdefense.org/de...   Increased cancers after mRNA vaccines Watch this video at- https://youtu.be/3dnIGqUlluc?si=sDbAdXTgOsCiCLev Dr. John Campbell 3.25M subscribers 143,152 views Sep 5, 2025 COVID-19 vaccination, all-cause mortality, and hospitalization for cancer: 30-month cohort study in an Italian province https://pubmed.ncbi.nlm.nih.gov/40881... https://pmc.ncbi.nlm.nih.gov/articles... https://www.thefocalpoints.com/p/brea... The rate of first hospitalization for cancer of any site Unvaccinated group: 0.85% Vaccinated group (one or more doses): 1.15% N = 296,015 population Hospital admission with a cancer diagnosis, 3,124 (p less than 0.001). Vaccination with at least one dose Colon-rectal cancer HR: 1.34 Breast cancer HR: 1.54 Bladder cancer HR: 1.62 After three or more vaccine doses Breast cancer HR: 1.36 Bladder cancer HR: 1.43 All significant After one dose (180 days after) Rate of first hospital admissions for cancers All cancers: up 23% significant Colorectal: up 34% significant Lung: down = 10% Breast: up 54% significant Uterine: up = 75% Ovarian: up = 65% Prostate: up = 1% Bladder: up 62% significant Thyroid: up =58% Haematological: up = 33% After three dose (180 days after administration of third dose) All cancers: up = 9% Colorectal: up = 14% Lung: down = 5% Breast: up=36% significant Uterine: up = 20% Ovarian: up = 86% Prostate: down = 3% Bladder: up=43% significant Thyroid: down = 3% Haematological: up = 5% More about the study Population-wide cohort analysis Evaluating the risk of all-cause death and cancer hospitalization by SARS-CoV-2 immunization status. National Health System official data, entire population, Pescara province, Italy Followed from June 2021 (six months after the first vaccination) to December 2023. 296,015 residents aged ≥11 years Hospital admission with a cancer diagnosis, 3,124 16.6% were unvaccinated 83.3% received ≥1 dose 62.2% ≥3 doses. Compared with the unvaccinated, those receiving ≥1 dose showed a significantly lower likelihood of all-cause death Cancer hospitalization was significant only among the subjects with no previous SARS-CoV-2 infection Some cancer risks went down after 1 year (relative to 180 days) (But breast, ovarian and bladder went up at one year relative to 180 days after 1 vaccine dose) Given that it was not possible to quantify the potential impact of the healthy vaccinee bias and unmeasured confounders, these findings are inevitably preliminary.  

Brothers In Lows - Para Pa Mi [Open Bar Music] Mario Reyes, AMEME - Power (Markus Martinez Remix Extended Mix) [One Tribe Records] Siwell, Gianni Ruocco - Cachondea (Extended Mix) [TROPICA RECORDS] Yas Cepeda, Aaron Sevilla - Tiburon (Original) [AFRODISE] DJ Gaston - This Night to You (Original Mix) [STMUL8] Mijangos, Ramiro Brett - Soda Groove (Original Mix) [House Tribe Records] TEKO - Boladao (Extended Mix) [Gasolina] Roland Clark - I Get Deep (Kashovski Extended Remix) [Get Physical Music] Taranco - Drop Me A Beat (Extended Mix) [Sola] Pete Tha Zouk, Hugo Villanova - La Bonita (Extended Mix) [Kaos Records] Samba De Malandro - Liquid Music (Original Mix) [MK17] Zsak, Andrea Lane - Por Eso (Extended Mix) [There Was Jack] Vinter (BR) - Space Pump ((Space Jam) (Extended Mix)) [Nervous Records] Nick Curly, Rony Seikaly - Floating Point (Extended Mix) [8Bit]

In this episode of 'Colon Meet Cancer,' Ben recounts the surprising success story of Henrik Gretzky's Symphony Number Three, how badly it was initially received by the musicology world and draws a surprising parallel to his chemotherapy journey. He shares the complex experience of managing an increasing range of chemo side effects, including white blood cell treatments, pain, and hair loss. Ben candidly discusses his struggles with memory fog, the challenges it brings, and the ensuing emotional toll manifested as depression and self-reflection. Despite the adversities, he highlights the importance of humor, intellectual stimulation, and staying hopeful. One of the tools he has used has been late night reflections on controversial topics, and he closes out the episode with Ben by sharing one of those midnight reflections - the potential risks and benefits of AI in healthcare. This week's t-shirt, gifted by Andy Seale, features the slogan 'Make America Democratic Again.' 00:00 Introduction: A Surprising Symphony 02:53 The Onset of Chemotherapy 04:37 Managing Side Effects 10:13 Chemo Brain and Memory Fog 14:59 Depression and Self-Reflection 18:45 AI and Its Implications 23:35 Humor as a Coping Mechanism 25:32 Conclusion: Gratitude and Hope Join the Conversation! How do you see the future of global health unfolding? Share your thoughts in the comments! Subscribe & Stay Updated! Listen on Spotify, Apple Podcasts, or your favorite podcast platform. Watch on YouTube & subscribe for more in-depth global health discussions: www.youtube.com/@shotarmpodcast

The EC Show: Enasia Colon Take on FSU vs Bama College Football Chaos, FSU Soccer, Football Talk & More!This week on The EC Show, Enasia Colon brings the heat as she breaks down the FSU vs Bama clash

Are ultrarunners at higher risk of colon cancer? Can scrolling before a workout actually make you slower? And is muscle damage( not gut issues) the biggest reason athletes DNF ultras? This episode dives deep into three new studies that every endurance athlete should know about.Zoë and TJ break down the recent New York Times article on colon cancer risk in marathoners and ultrarunners, explaining why the headlines caused panic, what the data really says, and how to think critically about risk. They then discuss surprising new evidence that social media use before training may blunt your skill development and endurance. Finally, they dig into a groundbreaking study on muscle damage in ultras, why durability may matter more than VO₂max, and practical training strategies to keep your legs from blowing up on race day.Scroll to the bottom to see our citations for this episode!⏱️ TIMESTAMPS00:00 – Intro + Run Rabbit taper talk09:42 – Colon cancer study explained28:50 – Social media and mental fatigue in athletes42:00 – Muscle damage vs. GI distress in ultras01:20:15 – Practical training takeaways

Oceannn - Mueve (Extended Mix) [Hotfingers] Alvii Ferrer - Juntaro Music (Original Mix) [High Pressure Music] Fantomel, Kate Linn - Dame Un Grrr (Provi Remix) (Extended Mix) [Make The Girls Dance Records] Lucas Rotela - Trap Picheo (Original Mix) [Weird Recordings] Samba De Malandro - palm of my hands (Original Mix) [MK17] Drums Atack - Me encanta (Original Mix) [Be colors music] Adeva, Groove P - Hold On Honey (Extended Mix) [Pleased As Punch] Armand Vibe - Pega Pega (Extended) [Marin Music] Draxx (ITA) - Flexin (Extended Mix) [Make The Girls Dance Records] Adam Asenjo, Hendi - Toma (Extended Mix) [HOTOVEN] Robert DB - The Future Of Mankind (Original Mix) [Bad Music] The BeatBoy's - Warping (Original Mix) [Moan] Kevin Yost - Naive (Original Mix) [TSOY]

ResourcesClick here to learn about United Ostomy Associates of America (UOAA) National Quality Ostomy Care Campaign, including the Ostomy and Continent Diversion Patient Bill of Rights,.Click here to view a list of patient resources that the WOCN Society has curated, including services, products, and publications. You can also bookmark and/or share the following web address with your colleagues and patients: IDeserveaWOCNurse.com.Click here to view and use the Peristomal Skin Assessment Guide for Clinicians and Consumers,. You can also bookmark and/or share the following web address with your colleagues and patients: psag.wocn.org.Click here to learn more about Janet's session at WOCNext® 2025, “I Have an Ostomy, Where can I go?: Challenges of Setting Up An Ostomy Clinic,.”The WOCN Society, in collaboration with the American Society of Colon and Rectal Surgeons (ASCRS) and the American Urological Association (AUA), developed the educational resources to assist clinicians in selecting an effective stoma site. Click here to review these resources.If you're a healthcare professional looking to deepen your knowledge of ostomy care, explore the joint WOCN and ASCRS Ostomy Care Management (OCM) Program—an evidence-based, online education designed to enhance care delivery and improve outcomes for individuals living with an ostomy. Click here to learn more.Journal of Wound, Ostomy, and Continence Nursing (JWOCN®) articles referenced in this episode:Bridging the Gap: Perceived Educational Needs in the Inpatient to Home Care Setting for the Person With a New OstomyLessons Learned About Peristomal Skin Complications Secondary Analysis of the ADVOCATE TrialOstomy and Continent Diversion Patient Bill of Rights Research Validation of Standards of CareOther articles referenced in this episode: The ostomy leak impact tool: development and validation of a new patient-reported tool to measure the burden of leakage in ostomy device usersImpact of stoma leakage in everyday life: data from the Ostomy Life Study 2019Factors impairing quality of life for people with an ostomy About the SpeakerJanet has enjoyed 40 years in WOC Nursing. Although her early nursing career focus was critical care as a certified critical care registered nurse she certified as a CWOCN in 1985. In 1996, she embarked in a private WOC practice, first as a partnership and then as sole proprietor practicing across the continuum with a focus on ostomy care coupled with a passion for patients attaining their desirable quality of life. Janet worked in outpatient ostomy clinics serving different populations and challenges... adding a bit of spice to her practice and recently retired from patient care.Janet lectures nationally and internationally, has published on Quality of Life of People Living with an Ostomy and co-authored both a home study course on Wound Management & Healing and an educational video on Common Perineal Skin Injuries, and. She participates in Ostomy and Incontinence Associated Dermatitis research and actively participates with WOCN and industry to move ostomy care forward. Her peers awarded her the PCR* ET Nurse of the Year Award in 1996, PCR* President's Award in 2000 and PCR* Professional Educational Award in 2004.*PCR stands for the Pacific Coast Region of the WOCN Society, what is now known as the Pacific Coast Chapter of the WOCN Society (or PCC for short). The WOCN Society has 11 chapters throughout the country that support WOCN members at a local level with resources, education, networking opportunities, social gatherings, timely information, and more. For additional information, please visit wocn.org/Chapters. Editing and post-production work for this episode was provided by The Podcast Consultant.

Freelance writer and founder of Doors Open Dishes Nicole Schnitzler joins Bob Sirott to talk about some of her favorite farmers markets in the Midwest, such as Elawa Farm in Lake Forest and Farrand Farm in Colon, Michigan. She also discusses her background growing up on a farm and what inspired her to create Doors […]

08-26-25 - Man Had 25 Inch Long Live Eel Removed From His Colon BOSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

08-26-25 - Man Had 25 Inch Long Live Eel Removed From His Colon BOSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Michael Colon's journey to create the greatest science fiction comic book reflects his passion for fantasy and science fiction, blending elements of drama and psychological fiction. Michael's quest for validation and growth fueled his fearless pursuit of publication. What inspired him, and how did he achieve this remarkable journey? “The greatest comic book tale ever told” and “The Gift From Aelius” by Michael Colon.

Join Dr Brad Leech and ambassador Lisa Costa-Bir on her inaugural podcast on all things gut inflammation. Brad breaks down the importance of functional testing for assessing inflammation, with a detailed discussion on interpreting the four major tests: calprotectin, lactoferrin, occult blood and secretory IgA. Learn about the importance of personalising treatment for patients with gut inflammation and how to effectively use (and dose) key anti-inflammatory herbs and nutrients for optimal efficacy. Clinical take-homes for use in your practice will also include dietary recommendations and an interesting discussion on colon cleansing. COVERED IN THIS EPISODE (00:50) Welcoming Dr Brad Leech (02:02) Intestinal inflammation vs intestinal permeability (03:29) Signs and symptoms of intestinal inflammation (06:43) Functional assessments for intestinal inflammation (23:41) How the microbiome influences intestinal inflammation (36:05) When should we test our patients? (42:07) Treatment options for combating intestinal inflammation (46:32) Which diets improve intestinal inflammation and why? (50:00) Colon cleansing: do or don't? (53:08) Thanking Brad and key takeaways Find today's transcript and show notes here: https://www.bioceuticals.com.au/education/podcasts/intestinal-inflammation-clinical-definition-testing-treatment Sign up for our monthly newsletter for the latest exclusive clinical tools, articles, and infographics: www.bioceuticals.com.au/signup/ DISCLAIMER: The information provided on fx Medicine by BioCeuticals is for educational and informational purposes only. The information provided is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you learn here raises questions or concerns regarding your health.

Ninetree - Rain On Me (Original Mix) [Tamango Records] Bauti Tesei - Shake Dat (Extended Mix) [Catch & Release] Andrea Lane, Zsak - Por Eso (Extended Mix) [There Was Jack] Roger Sanchez, Hugel - Go Again (Extended Mix) [Virgin] Emery Bex, Karretero - A Mi Manera (Extended Mix) [NUSONIDO] Tujamo, Plastik Funk - WHO (Atcg Remix, Extended Mix) [CITY STARS RECORDS] CamelPhat, Elderbrook, ARTBAT - Cola (ARTBAT Extended Remix) [Defected] TWENTY SIX -Muddy Waters (Extended Mix) [Defected] Thomas Garcia, Zuni - Pulso Eterno (Extended Mix) [Make The Girls Dance Records] Alex Amaro – Boss [Decypher] Ddoblé, Marcelo (US), Twogee - Hard Like 88 (Extended Mix) [Tranquilo] Anny Rendon - Groove Love (Original Mix) [Duff Music]

The EC Show: Fantasy Football Baby! Happy Birthday EJ! & Enasia Colon FSU Soccer Update!

Colon irritable: descubre cómo apagar la inflamación, recuperar tu flora intestinal y ganar la batalla por tu salud digestiva

The EC Show: Enasia Colon Scores for FSU Soccer, Fantasy Football Madness & FOOTBALL IS BACK! ⚽️

It's a decision that can save your life. Colon cancer screening is crucial because it allows for early detection and removal of precancerous polyps, preventing or significantly improving outcomes for colorectal cancer, which is a leading cause of cancer deaths. When colorectal cancer is detected early, it's often highly treatable and curable.

Greg's butt is all good people!

Psalms 42

As Ben starts his first chemotherapy cycle, he explores the controversial yet essential role of chemotherapy in cancer treatment. He looks at its historical roots and tries to understand the scientific mechanisms of various chemotherapies. He shares an intimate look at the highs and lows of his first cycle of treatment, the importance of comprehensive, multidisciplinary care, as well as the physical and emotional aspects of cancer therapy. Ben's t-shirt this week celebrates the Ukrainian Alliance for Public Health. You can find out more about the Alliance and how you can help at https://aph.org.ua/en/home 00:00 Introduction and Preface 00:45 The Origins of Chemotherapy 02:33 Personal Experience with Chemotherapy 04:30 The Chemotherapy Process 07:25 Side Effects and Challenges 11:15 Living with Chemotherapy 17:25 Understanding Chemotherapy 22:16 The Vagal Response Incident 28:20 Conclusion and Acknowledgements

Dr. Sumanta (Monty) Pal and Dr. Kimmie Ng discuss the disturbing rise of early-onset gastrointestinal cancers, the unique challenges faced by younger patients, and key research that is shedding light on potential drivers of early diagnoses in colorectal cancer. TRANSCRIPT Dr. Sumanta (Monty) Pal: Hello, everyone. I'm Dr. Monty Pal, and I'm a medical oncologist and professor and vice chair of medical oncology at the City of Hope Comprehensive Cancer Center in Los Angeles. I'm really delighted to welcome you all to the ASCO Daily News Podcast as the show's new host. I'll be bringing you discussions with leaders in the oncology space on a variety of topics. I've been working hard with the ASCO team on picking the ideal topics to bring to you, and I'm really delighted to introduce my first guest, a dear friend, Dr. Kimmie Ng, to discuss this huge problem that we're seeing nowadays of early-onset GI cancers. Dr. Ng is the associate chief of the Division of Gastrointestinal Oncology at the Dana-Farber Cancer Institute, and she's an associate professor of medicine at Harvard Medical School in Boston. She serves as co-director of the Colon and Rectal Cancer Program. She's also the founding director of the Young-Onset Colorectal Cancer Center at Dana-Farber. I'm sure we'll talk a little bit about that today.  Just to note, our full disclosures are available in the transcript of this episode.  Dr Ng, it's so great to have you on the podcast. Thanks so much for joining us. Dr. Kimmie Ng: Thank you so much for having me. It's great to be here. Dr. Sumanta (Monty) Pal: I'm going to refer to you as Kimmie, if you don't mind, for the rest of the podcast here. Please, we'll go by first names, if you don't mind.  Your research has really done so much to help improve our understanding of early-onset GI cancers. You've done a lot of work to increase awareness in this space. I don't think there's a couple of months that passes by when I don't see you on television on Good Morning America or other shows really broadcasting this really critical message. I think there's a certain sensitivity that we all have to this issue, right? I mean, because receiving a cancer diagnosis at any age is very challenging, but I'm sure that young patients who face a colorectal cancer diagnosis have some very unique challenges. Could you give us a sense of some of those? Dr. Kimmie Ng: I think the other reason why so many people are interested in this and feel touched by this is that it's not just gastrointestinal cancers that are increasing in young people, but actually a multitude of different cancers have been rising in young individuals. And while it is difficult at any age to receive a cancer diagnosis, we do all know that young people getting a diagnosis like this do face unique challenges. Studies have shown that over 80% have children under the age of 18 when they are diagnosed with colorectal cancer, for example, under the age of 50. And many experience career and education disruptions. They are in what we call the ‘sandwich generation,' where they're not only taking care of young families or starting to think about starting a young family, but they're also taking care of elderly parents. So it's just a very busy stage of life, and to then be facing a usually terminal cancer diagnosis, it is extremely challenging. The other factors that we've seen that seem to be unique or more prevalent in young patients is that there are higher levels of psychosocial distress, depression, and anxiety, and a majority of patients do need medical attention and treatment for those things, whether it's medication treatment or whether it's counseling or support from psychosocial oncologists. And so the other big issue is fertility. We know that so many of the treatments that these young patients receive do permanently and negatively impact fertility. And for a person who is young, who may still be trying to expand their family or again start a family, it is very important that these young patients do receive counseling about fertility preservation prior to starting treatment. Dr. Sumanta (Monty) Pal: You know, it's so interesting you bring this up, and I think about a patient who's in their 40s diagnosed with this disease. They're in the same demographic as I am, as you are. You know, I'm 44 years old, and you know, I'm thinking about my 11- and 12-year-old and my aging parents, right? I mean, the dilemmas that you highlighted are precisely what I'm facing in life, and it's so true, right? If I had to take my day-to-day and superimpose on that a colorectal cancer diagnosis, it would just be problematic in so many spheres, so many spheres. Dr. Kimmie Ng: Absolutely. And because we did think going into this, starting our Young-Onset Colorectal Cancer Center, that these patients will need unique supports, we did conduct a qualitative study and held some focus groups of young-onset colorectal cancer patients as well as their caregivers. And we really identified four primary themes that I think reflect a lot of the experience of patients with cancer, no matter what type of cancer when they're diagnosed young. And the first is the need, feeling overwhelmed by the healthcare system, and the need for patient navigation. As we know, a lot of these patients are previously healthy before they're facing this very serious diagnosis. The second is the need for peer-to-peer support, where they really value connecting with other young patients going through a similar experience. The third, we talked about already, the need for kind of formal psychosocial support in the form of psychosocial oncologists or psychiatrists or social workers. And the last is an interest in research. They are really very invested in getting germline genetic testing as well as somatic genomic profiling to help guide their therapy. Dr. Sumanta (Monty) Pal: That's really encouraging to hear that they themselves are interested in participating in research. I mean, obviously, that's a great way to move the field forward. I view your area of work here as being such a vexing problem because no matter what way you slice it, young-onset colorectal cancer still remains a relatively small proportion of all diagnoses. So how do you go about studying this phenomenon? I mean, it must be challenging to really sort of investigate underlying causes when ostensibly this is still a small piece of the pie. Dr. Kimmie Ng: That is such a great question and is one of the challenges me and my research team think about every single day. As you mentioned, one of the major barriers is that although these cancers are rising in young people, the absolute number of patients being diagnosed is still relatively small, and if it's going to take large scale epidemiologic studies to really understand, for example, what the dietary and lifestyle risk factors are, you need a considerable number of patients in order to have enough power to reach definitive conclusions.  And so this is where it is so important to collaborate. Any single institution is not going to see enough young-onset patients with colorectal cancer to be able to do this work on their own. And so I have really been intent on establishing an international prospective cohort study of patients with young-onset colorectal cancer so that we can increase the numbers of patients we partner with to try to answer these questions, but also so that we can study this on a global scale, because unfortunately this is not something that's just plaguing the United States. It is actually happening in multiple countries around the world. So that is one barrier.  The second, I would say, is that we think it's early life exposures to whatever environmental factor it is that's causing the rise that is likely contributing the most. And so if you imagine how difficult it would be to start studying individuals from when they're children through adolescence, through adulthood, and then all the way until a cancer diagnosis is obtained, a study like that would take too long, would cost too much, and really wouldn't be feasible. So we need to think of alternative ways to really try and answer this question of what is driving this rise in young-onset colorectal cancer. Dr. Sumanta (Monty) Pal: Honestly, Kimmie, this seems like almost an unfair question in the context of what you just mentioned, the challenges in terms of ascertaining causality, right? I'll tell you, I cheated a little bit ahead of this podcast. Kimmie and I had dinner together in Los Angeles a couple months ago. She came out to deliver a Presidential Lectureship at City of Hope. We were delighted to have her. And we did have a couple of thoughts exchanged over potential drivers of these early diagnoses, leaning on perhaps one of the things that you and I are both interested in, the microbiome. But amongst all these things, vitamin D, microbiome, etc., and I won't hold you to this, do you have at least a general sense of what might be contributing to this early-onset phenomenon? Dr. Kimmie Ng: Yeah, as we talked about during my visit there to City of Hope, we do hypothesize that it is a complex interaction between our exposome, which is everything we are exposed to in our environment, which does include diet and lifestyle factors, interacting with host immunity and antitumor immunity, and as well as the microbiome and shaping the composition and diversity of the gut microbiome that are likely interacting to increase susceptibility to colorectal cancer at a younger age. And I will say one of the biggest discoveries, if you will, about what might be driving young-onset colorectal cancer was published a few months ago in Nature. And that paper identified a specific mutational signature caused by the genotoxin colibactin, which is often produced by an organism called pks+ E. coli, as being much more prevalent in younger patients with colorectal cancer than older patients. And so while it doesn't explain necessarily all of young-onset colorectal cancer and why it's rising, it does give us a clue that the microbiome is likely very important in perhaps why this is rising in young people. Dr. Sumanta (Monty) Pal: After you mentioned it, I went back and dove deep into that paper. I was fascinated, fascinated by the content there. And this is just a massive exploration across thousands of patients worldwide. So, I mean, if there is a way to get at least some hint of what's driving this phenomenon, I suppose that's it. So thank you for pointing me in the direction of that manuscript. Now that we've addressed the issue of diagnosis, if we could just, you know, verge on the topic of treatment, right? And this is something that I struggle with. When I have my young patients with kidney cancer, I don't know necessarily that my treatment paradigm changes a whole heck of a lot. I guess what I will say is I might be a little bit more aggressive about concepts like definitive management with surgery. I suppose perhaps their treatment tolerance is a little bit higher. But tell us about the setting of young-onset colorectal cancer. Is the philosophy any different in terms of the actual sort of management of these patients? Dr. Kimmie Ng: That's a great question, and actually I was honored to participate in the first international consensus guidelines group to try to come up with uniform recommendations for how to treat young patients with colorectal cancer. And you know, the overall consensus is just as you said, the medical care of these young patients right now is really not that much different than that of an older patient with colorectal cancer. There are a couple of distinctions. One is that all young patients should get germline genetic testing, given that there is a higher prevalence of pathogenic germline variants when you are diagnosed at a young age. And the second is what we've already talked about, which is that all young patients should be referred for counseling about fertility preservation prior to starting treatment. But otherwise, the chemotherapy regimens recommended, you know, surgery, radiation, all of that seems very similar to older patients. I will say that because most of our young patients with colorectal cancer are diagnosed with left-sided cancers, including rectal cancers, where some of the treatment may be morbid and result in lifelong complications, we do consider de-escalation of therapy and try to consider the long-term implications when it's safe to do so and won't compromise outcomes. The other concerning thing is that younger patients don't necessarily have a better prognosis than older patients. And multiple studies have shown this, that even though we both often treat younger patients more aggressively – they more often receive multi-agent chemotherapy, and more often undergo surgery and radiation – their survival is not necessarily correspondingly better than an older patient with colorectal cancer. So that suggests to us that maybe these cancers are indeed biologically different and perhaps more aggressive or perhaps less responsive to treatment. And so that is some of the focus of our research too, to understand what is actually different about these cancers and how they respond to treatment. Dr. Sumanta (Monty) Pal: It's such a paradox, isn't it, right? Because you just brought this to my mind. I guess on the one hand, our younger patients may be able to tolerate perhaps a greater amount of chemotherapy, targeted therapy, etc. But you're absolutely right. I mean, they do sort of have these lingering issues with side effects that may persist for much longer than the 80- or 90-year-old that we're treating in the clinic. I mean, these tend to be sort of lifelong consequences and sequelae that they're dealing with. So that really does evolve to be a challenge. You've kind of changed my mindset there a little bit. Dr. Kimmie Ng: Yeah, I do think survivorship issues and long-term complications of therapy do need to be considered, especially for a young person who we hope will live a very, very long time. And so part of the work that our Young-Onset Colorectal Cancer Center is doing, we are participating in a pilot navigation study where we navigate patients to survivorship earlier than we typically would, perhaps, for an older patient. And that's so we can get a head start on addressing some of those potential complications of therapy and hopefully mitigate them so that they don't become an issue long term. Dr. Sumanta (Monty) Pal: Do you think there's a role for de-escalation studies formally in these young populations of patients? Dr. Kimmie Ng: I think de-escalation studies are important overall, and specifically for locally advanced rectal cancer, which again is one of the most common types of colorectal cancer diagnosed in our young patients, there are certain populations that may be able to forgo the radiation treatment to the pelvis, for example, and there's more and more patients who now may become candidates for non-operative management where they may not necessarily need to have their rectal cancer surgically removed. And elimination potentially of both of those modalities of treatment can really avoid some of the most serious and morbid complications that often occur with these treatments. Dr. Sumanta (Monty) Pal: Really interesting. Now, this is not and will never be a political podcast, but you know, obviously we're dealing with the consequences of changes on funding and so forth that have evolved over time. And I think it's worth sort of speculating how the landscape of research may change on account of that. Could you comment perhaps a little bit on how some of the funding cuts that we've seen recently at the NIH might affect the body of work that you're so integrally involved in? Dr. Kimmie Ng: I am honestly very worried about the current funding environment. Colorectal cancer is the third most commonly diagnosed cancer among men and women in the United States and globally, and when you combine men and women together, the second leading cause of cancer death. But proportionally, we receive much less funding for colorectal cancer compared to other cancer types. And my thoughts have always been that perhaps this is because there is this stigma around colorectal cancer and maybe some of the symptoms associated with colorectal cancer. And so on top of that, to have additional challenges in obtaining funding, I worry what it will do to the pace of progress for especially young patients with this disease. Also, because of some new stipulations that perhaps international collaborations are being discouraged, I also worry about that aspect of it because young-onset colorectal cancer and gastrointestinal cancers in general is a global phenomenon happening in multiple countries around the world. And if we are to understand what the environmental factors are affecting the different rates of rise in these different countries, we do so much need that international collaboration. So yes, I am worried, and I do hope that conversations like this will spark an awareness of the need for more funding and continued funding into this disease. Dr. Sumanta (Monty) Pal: I will say that, and the audience can't see this because this is an audio program, but I'm wearing my Southwest Oncology shirt here, a SWOG, and it's one of the National Cancer Institute-funded cooperative groups. And you know, I was recently dismayed to find that, you know, funding got cut for international collaborations and enrollment in South America and Latin America. And this was traditionally actually a mainstay of our enrollment for many trials, including trials in rare cancers that present themselves in younger patients in the GU space. So, I completely agree with you. We've got to do something to address this funding issue to make sure that this body of work, both yours and mine, continues, without a doubt. Kimmie, this has been a delightful conversation. I really want to thank you for, you know, leading the charge in the young-onset colorectal cancer space, and you've done so much tremendous work here. Dr. Kimmie Ng: Thank you for having me. Dr. Sumanta (Monty) Pal: If you value the insights that you hear on the ASCO Daily News Podcast, please rate, review, and subscribe wherever you get your podcasts. And again, thank you for joining us today. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Find out more about today's speakers:   Dr. Sumanta (Monty) Pal @montypal Dr. Kimmie Ng @KimmieNgMD Follow ASCO on social media:    @ASCO on Twitter   ASCO on Bluesky  ASCO on Facebook    ASCO on LinkedIn    Disclosures:   Dr. Sumanta (Monty) Pal: Speakers' Bureau: MJH Life Sciences, IntrisiQ, Peerview Research Funding (Inst.): Exelixis, Merck, Osel, Genentech, Crispr Therapeutics, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical Travel, Accommodations, Expenses: Crispr Therapeutics, Ipsen, Exelixis Dr. Kimmie Ng: Honoraria: Seagen, GlaxoSmithKline Consulting or Advisory Role: CytomX Therapeutics, Jazz Pharmaceuticals, Revolution Medicines, Abbvie, Bayer, Pfizer, Agenus, Johnson & Johnson/Janssen, Etiome, AstraZeneca Research Funding (Inst.): Pharmavite, Janssen Other Relationship: JAMA

The EC Show: Fantasy Football, Baseball Rumbles & Enasia Colon Talks FSU Soccer ⚽️

Texas state representatives flee the state despite threats of arrest from Governor Greg Abbott (R). Rep. Jasmine Crockett (D-Texas) has fighting words for President Trump and Republicans. Illinois congresswoman: Guatemalan first, American second. Senator Elizabeth Warren (D-Mass.) is all in on Zohran Mamdani, and so are young socialists. Republican mayoral candidate Curtis Sliwa drops his beret. President Trump's physical fitness council has a lot of big names … that apparently aren't easy to pronounce. Food stamps and Food pyramid changes coming. Colon cancer rates skyrocket in young people … but why? Canada, get your fires under control. Jim Acosta has an “interview” with an AI representation of a Parkland victim. AI out of control? CNN admits that Donald Trump has already had a tremendous amount of influence for the nation. Ukraine refugees headed to the U.S. Does Marco Rubio ever sleep? Looking ahead at the 2028 Republican field. Who is stopping the food aid from getting to residents of Gaza? Pamela Anderson looks different. 00:00 Pat Gray UNLEASHED! 00:20 Arrest Warrants for Texas Democrats 03:35 Texas Democrats' Message to Republicans 05:51 Who is Paying for Texas Dems? 07:09 Ramon Romero Runs Away from Texas 09:32 Dustin Burrows Signs Arrest Warrants 11:24 Ramon Romero Attacks Greg Abbott 15:56 Jasmine Crockett Calls Trump a POS 20:24 Delia Ramirez is a Guatemalan First 24:02 Cory Booker Asked about Zohran Mamdani 27:32 Elizabeth Warren Fully Supports Zohran Mamdani 34:15 Socialism 2025 Controls Zohran Mamdani Campaign 43:58 Trump Brings Back Presidential Fitness Test 50:10 Changes to Food Stamps Benefits 52:55 RFK Jr. Explains New Dietary Guidelines 59:55 Jim Acosta Interviews AI of Parkland Victim?! 1:06:24 Ozzy Osbourne AI 1:09:06 CNN Praises Trump's Tariffs? 1:14:33 Ukraine Refugees in America 1:16:10 Marco Rubio's Many Hats 1:19:38 GOP in 2028 Learn more about your ad choices. Visit megaphone.fm/adchoices

El 3 de agosto de 1492 zarpó del Puerto de Palos la primera expedición de Cristóbal Colón, un viaje que cambiaría el rumbo de la historia.

Our "Listen Up" panelists are back and ready for a Colon-oopscopy as they deep dive into Episode 16! S1. E16 - ⁠⁠⁠⁠⁠⁠⁠⁠Colon-oopscopy- Mon, Feb 14, 2005Director - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Lynn M. McCrackenWriters - ⁠⁠⁠⁠⁠⁠⁠⁠Tony Kornheiser, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Jeff Martin, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Jamie RhonheimerWhen Bernie has an insurance-required colonoscopy (a miniature camera on a tube right up the rectum), Tony is loudly approving and supportive as he tags along for moral support--but Dr. Lou Swerling seizes the opportunity to schedule Tony for the next morning. Giving Mickey's hospital orderly observations and Dana's "childbirth's worse" routine, he can't even milk it for sympathy. It gets worse: Swerling finds a probably benign polyp but still schedules Tony's butt for the scalpel next day. His attempts to sneak out are foreseen and countered. While he is being prepped, Swerling recognizes Dana as a college date's friend, and Tony fears being "conveniently lost in OR" and runs, albeit only to maternity. So the surgery goes through, but the weirdest twist is in the tail.EMAIL: WTFCPODNET@GMAIL.COM or www.loyallittlespod.com https://www.youtube.com/watch?v=czzbafs4vw8&list=PLKiPEmIz-2gtIo-tInY-kIa6p-B1xF77y&index=16

Fabrizio Copano! Comedian! Friend! Delight! More! His new special "From the Future" is out now! About Fabrizio Copano: NYC-based comedian Fabrizio Copano was the first South American to shoot an original comedy special for Netflix and is a Comedy Cellar regular. He co-wrote and starred in one of Chile's highest grossing comedies, Barrio Universitario (2013). His credits also include: actor and writer in the hit Chilean comedy show El Club de la Comedia, late night show host of El Late de Copano, and host of La Culpa es de Colon for Comedy Central Latin America. Fabrizio made his American late-night debut on The Late Late Show with James Corden, was included in the Just For Laughs 2022 New Faces cohort, and was a part of CBS's 2025 Comics to Watch Showcase. We have a great chat! You can have a great listen! And this is only the first HALF of our chat! For part two, subscribe via Apple Podcasts OR simply click on over here to Patreon!

The EC Show: RIP Hulk Hogan Fantasy Football Draft & Enasia Colon's First Day at FSU Soccer.Get ready for a hilarious and heartfelt ride with this week's all-new episode of The EC Show featuring Emilio Colon Sr Enasia Colón Emilio Colon Jr and Joseph Buto. This time, the crew breaks down their wild fantasy football draft coming soon Enasia Colon's first day at FSU soccer practice her media day and much more.Expect straight-up laughs, real talk, and that unfiltered EC chemistry that keeps listeners coming back week after week.

Want better energy, improved digestion, and lower disease risk? It all starts with a healthy colon! Join Dr. Carrie Lam as she reveals simple, effective lifestyle habits—like eating fiber-rich foods, staying hydrated, and getting probiotics—that promote colon health and boost your overall well-being. Learn how exercise, regular screenings, and smart nutrition can make all the difference.Trying to find an integrative medicine or functional medicine doctor who understands what you're going through? Lam Clinic does Telemedicine all over the world and is only a phone call away.1. Educate yourself by visiting our website: www.lamclinic.com2. Call our office at 714-709-8000 to schedule an appointment.FIND US ONLINE HERE:» Website: https://www.lamclinic.com/» Facebook: https://www.facebook.com/lamclinic» Instagram: https://www.instagram.com/lam_clinic/» Tiktok: https://www.tiktok.com/@lamclinic» YouTube: https://www.youtube.com/LAMCLINIC

John Zmirak "The Tapeworms in the Colon of America Refused to Let Go of Power." The Eric Metaxas Show   Jul 22 2025   John Zmirak on the outgoing admin 2016 scandal "The tapeworms in the colon of America refused to let go of power." The Eric Metaxas Show- Eric talks to John Zmirak.  More at: stream.org John Zmirak is a senior editor at The Stream and author or coauthor of 14 books, including The Politically Incorrect Guide to Immigration and The Politically Incorrect Guide to Catholicism. His newest book is No Second Amendment, No First.   -----------------------------------------------------------------------------------------------  John Zmirak makes his weekly appearance and covers current events and shares recent articles available at-   https://stream.org/author/johnzmirak/ Watch Eric Metaxas on Rumble-  https://rumble.com/c/TheEricMetaxasRadioShow  The Eric Metaxas Show- https://metaxastalk.com/podcasts/ Eric Metaxas Show on Apple Podcasts-    https://podcasts.apple.com/us/podcast/the-eric-metaxas-show/id991156680 Check out- Socrates in the City   Find All of John Zmirak Articles at- https://stream.org/author/johnzmirak/   John Zmirak is a Senior Editor of The Stream. He received his B.A. from Yale University in 1986, then his M.F.A. in screenwriting and fiction and his Ph.D. in English in 1996 from Louisiana State University. He has been Press Secretary to pro-life Louisiana Governor Mike Foster, and a reporter and editor at Success magazine and Investor's Business Daily, among other publications. His essays, poems, and other works have appeared in First Things, The Weekly Standard, The Atlanta Journal-Constitution, USA Today, FrontPage Magazine, The American Conservative, The South Carolina Review, Modern Age, The Intercollegiate Review, Commonweal, and The National Catholic Register, among other venues. He has contributed to American Conservatism: An Encyclopedia and The Encyclopedia of Catholic Social Thought. From 2000-2004 he served as Senior Editor of Faith & Family magazine and a reporter at The National Catholic Register. During 2012 he was editor of Crisis. He is author, co-author, or editor of twelve books, including Wilhelm Ropke: Swiss Localist, Global Economist, The Grand Inquisitor and The Race to Save Our Century. His newest book is No Second Amendment, No First. Zmirak can be found at https://stream.org/author/johnzmirak/   John Zmirak is a senior editor at The Stream and author or co-author of ten books, including The Politically Incorrect Guide to Immigration and The Politically Incorrect Guide to Catholicism. He is co-author with Jason Jones of “God, Guns, & the Government.”   John Zmirak's new book: No Second Amendment, No First  by John Zmirak  Available March 19, 2024 Today's Left endlessly preaches the evils of “gun violence." It is a message increasingly echoed from the nation's pulpits, presented as common-sense decency and virtue. Calls for “radical non-violence” are routinely endowed with the imprimatur of religious doctrine.   But what if such teachings were misguided, even damaging? What if the potential of a citizenry to exercise force against violent criminals and tyrannical governments is not just compatible with church teaching, but flows from the very heart of Biblical faith and reason? What if the freedoms we treasure are intimately tied to the power to resist violent coercion?  This is the long-overdue case John Zmirak makes with stunning clarity and conviction in No Second Amendment, No First. A Yale-educated journalist and former college professor, Zmirak shows how the right of self-defense against authoritarian government was affirmed in both the Old and New Testaments, is implied in Natural Law, and has been part of Church tradition over the centuries.   --------------------------------------------------------------------  --------------------------------------------------------------------  Check out our ACU Patreon page: https://www.patreon.com/ACUPodcast   HELP ACU SPREAD THE WORD!  Please go to Apple Podcasts and give ACU a 5 star rating. Apple canceled us and now we are clawing our way back to the top. Don't let the Leftist win. Do it now! Thanks. Also Rate us on any platform you follow us on. It helps a lot. Forward this show to friends. Ways to subscribe to the American Conservative University Podcast Click here to subscribe via Apple Podcasts Click here to subscribe via RSS You can also subscribe via Stitcher FM Player Podcast Addict Tune-in Podcasts Pandora Look us up on Amazon Prime …And Many Other Podcast Aggregators and sites ACU on Twitter- https://twitter.com/AmerConU . Warning- Explicit and Violent video content.   Please help ACU by submitting your Show ideas. Email us at americanconservativeuniversity@americanconservativeuniversity.com   Endorsed Charities -------------------------------------------------------- Pre-Born! Saving babies and Souls. https://preborn.org/ OUR MISSION To glorify Jesus Christ by leading and equipping pregnancy clinics to save more babies and souls. WHAT WE DO Pre-Born! partners with life-affirming pregnancy clinics all across the nation. We are designed to strategically impact the abortion industry through the following initiatives:… -------------------------------------------------------- Help CSI Stamp Out Slavery In Sudan Join us in our effort to free over 350 slaves. Listeners to the Eric Metaxas Show will remember our annual effort to free Christians who have been enslaved for simply acknowledging Jesus Christ as their Savior. As we celebrate the birth of Christ this Christmas, join us in giving new life to brothers and sisters in Sudan who have enslaved as a result of their faith. https://csi-usa.org/metaxas   https://csi-usa.org/slavery/   Typical Aid for the Enslaved A ration of sorghum, a local nutrient-rich staple food A dairy goat A “Sack of Hope,” a survival kit containing essential items such as tarp for shelter, a cooking pan, a water canister, a mosquito net, a blanket, a handheld sickle, and fishing hooks. Release celebrations include prayer and gathering for a meal, and medical care for those in need. The CSI team provides comfort, encouragement, and a shoulder to lean on while they tell their stories and begin their new lives. Thank you for your compassion  Giving the Gift of Freedom and Hope to the Enslaved South Sudanese -------------------------------------------------------- Food For the Poor https://foodforthepoor.org/ Help us serve the poorest of the poor Food For The Poor began in 1982 in Jamaica. Today, our interdenominational Christian ministry serves the poor in primarily 17 countries throughout the Caribbean and Latin America. Thanks to our faithful donors, we are able to provide food, housing, healthcare, education, fresh water, emergency relief, micro-enterprise solutions and much more. We are proud to have fed millions of people and provided more than 15.7 billion dollars in aid. Our faith inspires us to be an organization built on compassion, and motivated by love. Our mission is to bring relief to the poorest of the poor in the countries where we serve. We strive to reflect God's unconditional love. It's a sacrificial love that embraces all people regardless of race or religion. We believe that we can show His love by serving the “least of these” on this earth as Christ challenged us to do in Matthew 25. We pray that by God's grace, and with your support, we can continue to bring relief to the suffering and hope to the hopeless.   Report on Food For the Poor by Charity Navigator https://www.charitynavigator.org/ein/592174510   -------------------------------------------------------- Disclaimer from ACU. We try to bring to our students and alumni the World's best Conservative thinkers. All views expressed belong solely to the author and not necessarily to ACU. In all issues and relations, we hope to follow the admonitions of Jesus Christ. While striving to expose, warn and contend with evil, we extend the love of God to all of his children. ----------------------------------------------------------------------------------------- 

Ben delves into the multifaceted experience of pain, beginning with a literary reference from Margaret Atwood. He shares personal anecdotes about blood draws, the insertion of a chemotherapy port, and the challenges of effectively communicating pain levels to healthcare professionals. Ben reflects on his nearly forty years' experience living with Crohn's disease, exploring different ways to describe pain, and examines various strategies for pain management, including medications like acetaminophen and oxycodone, and the antidepressant duloxetine. The episode also highlights historical and cultural contexts of pain and invites listeners to contribute to a virtual medicine cabinet of motivational and entertaining resources. 00:00 Introduction and Literary Preface 01:34 Personal Anecdotes and Blood Tests 02:08 Chemotherapy Port Installation 05:31 Experiencing and Describing Pain 13:38 Pain Management Strategies 18:25 Upcoming Chemotherapy and Final Thoughts https://www.ninds.nih.gov/health-information/disorders/pain

John Zmirak on the outgoing admin 2016 scandal "The tapeworms in the colon of America refused to let go of power."See omnystudio.com/listener for privacy information.

The incidence of early onset colorectal cancer (EOCRC) has been rising prompting the change in change in screening guidelines to 45 years of age for average risk patients. Join us for an in-depth discussion with guest speakers Dr. Andrea Cercek and Dr. Nancy You, where we provide a comprehensive look at the growing challenge of EOCRC. Hosts: - Dr. Janet Alvarez - General Surgery Resident at New York Medical College/Metropolitan Hospital Center - Dr. Wini Zambare – General Surgery Resident at Weill Cornell Medical Center/New York Presbyterian - Dr. Phil Bauer, Graduating Colorectal Surgical Oncology Fellow at Memorial Sloan Kettering Cancer Center  - Dr. J. Joshua Smith MD, PhD, Chair, Department of Colon and Rectal Surgery at MD Anderson Cancer Center - Dr. Andrea Cercek - Gastrointestinal Medical Oncologist at Memorial Sloan Kettering Cancer Center - Dr. Y. Nancy You, MD MHSc - Professor, Department of Colon and Rectal Surgery at MD Anderson Cancer Center Learning objectives:  - Describe trends in incidence of colorectal cancer, with emphasis on the rise of EOCRC. - Identify age groups and demographics most affected by EOCRC. - Summarize USPSTF recommendations for colorectal cancer screening. - Distinguish between screening methods (e.g., colonoscopy, FIT-DNA) and their sensitivity. - Understand treatment approaches for colon and rectal cancer (CRC) - Understand the role of mismatch repair (MMR) status in guiding treatment. - Outline the importance of genetic counseling and testing in young patients. - Discuss racial, ethnic, and socioeconomic disparities in CRC incidence and outcomes. - Describe the impact of cancer treatment on fertility and sexual health. -  Review fertility preservation options. - Identify the value of integrated care teams for young CRC patients. References: 1.         Siegel, R. L. et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013. JNCI J. Natl. Cancer Inst. 109, djw322 (2017). https://pubmed.ncbi.nlm.nih.gov/28376186/ 2.         Abboud, Y. et al. Rising Incidence and Mortality of Early-Onset Colorectal Cancer in Young Cohorts Associated with Delayed Diagnosis. Cancers 17, 1500 (2025). https://pubmed.ncbi.nlm.nih.gov/40361427/ 3.         Phang, R. et al. Is the Incidence of Early-Onset Adenocarcinomas in Aotearoa New Zealand Increasing? Asia Pac. J. Clin. Oncol.https://pubmed.ncbi.nlm.nih.gov/40384533/ 4.         Vitaloni, M. et al. Clinical challenges and patient experiences in early-onset colorectal cancer: insights from seven European countries. BMC Gastroenterol. 25, 378 (2025). https://pubmed.ncbi.nlm.nih.gov/40375142/ 5.         Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. (2019) doi:10.1136/gutjnl-2019-319511. https://pubmed.ncbi.nlm.nih.gov/31488504/ 6.         Cercek, A. et al. A Comprehensive Comparison of Early-Onset and Average-Onset Colorectal Cancers. J. Natl. Cancer Inst. 113, 1683–1692 (2021). https://pubmed.ncbi.nlm.nih.gov/34405229/ 7.         Zheng, X. et al. Comprehensive Assessment of Diet Quality and Risk of Precursors of Early-Onset Colorectal Cancer. JNCI J. Natl. Cancer Inst. 113, 543–552 (2021). https://pubmed.ncbi.nlm.nih.gov/33136160/ 8.         Standl, E. & Schnell, O. Increased Risk of Cancer—An Integral Component of the Cardio–Renal–Metabolic Disease Cluster and Its Management. Cells 14, 564 (2025). https://pubmed.ncbi.nlm.nih.gov/40277890/ 9.         Muller, C., Ihionkhan, E., Stoffel, E. M. & Kupfer, S. S. Disparities in Early-Onset Colorectal Cancer. Cells 10, 1018 (2021). https://pubmed.ncbi.nlm.nih.gov/33925893/ 10.       US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 325, 1965–1977 (2021). https://pubmed.ncbi.nlm.nih.gov/34003218/ 11.       Fwelo, P. et al. Differential Colorectal Cancer Mortality Across Racial and Ethnic Groups: Impact of Socioeconomic Status, Clinicopathology, and Treatment-Related Factors. Cancer Med. 14, e70612 (2025). https://pubmed.ncbi.nlm.nih.gov/40040375/ 12.       Lansdorp-Vogelaar, I. et al. Contribution of Screening and Survival Differences to Racial Disparities in Colorectal Cancer Rates. Cancer Epidemiol. Biomarkers Prev. 21, 728–736 (2012). https://pubmed.ncbi.nlm.nih.gov/22514249/ 13.       Ko, T. M. et al. Low neighborhood socioeconomic status is associated with poor outcomes in young adults with colorectal cancer. Surgery 176, 626–632 (2024). https://pubmed.ncbi.nlm.nih.gov/38972769/ 14.       Siegel, R. L., Wagle, N. S., Cercek, A., Smith, R. A. & Jemal, A. Colorectal cancer statistics, 2023. CA. Cancer J. Clin. 73, 233–254 (2023). https://pubmed.ncbi.nlm.nih.gov/36856579/ 15.       Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A. & May, F. P. Optimal Strategies for Colorectal Cancer Screening. Curr. Treat. Options Oncol. 23, 474–493 (2022). https://pubmed.ncbi.nlm.nih.gov/35316477/ 16.       Zauber, A. G. The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference? Dig. Dis. Sci. 60, 681–691 (2015). https://pubmed.ncbi.nlm.nih.gov/25740556/ 17.       Edwards, B. K. et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116, 544–573 (2010). https://pubmed.ncbi.nlm.nih.gov/19998273/ 18.       Cercek, A. et al. Nonoperative Management of Mismatch Repair–Deficient Tumors. New England Journal of Medicine 392, 2297–2308 (2025). https://pubmed.ncbi.nlm.nih.gov/40293177/ 19.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Molecular Heterogeneity in Early-Onset Colorectal Cancer: Pathway-Specific Insights in High-Risk Populations. Cancers 17, 1325 (2025). https://pubmed.ncbi.nlm.nih.gov/40282501/ 20.       Monge, C., Waldrup, B., Carranza, F. G. & Velazquez-Villarreal, E. Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer. Cancers 17, 1093 (2025). https://pubmed.ncbi.nlm.nih.gov/40227607/ 21.       Benson, A. B. et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J. Natl. Compr. Cancer Netw. JNCCN 19, 329–359 (2021). https://pubmed.ncbi.nlm.nih.gov/33724754/ 22.       Christenson, E. S. et al. Nivolumab and Relatlimab for the treatment of patients with unresectable or metastatic mismatch repair proficient colorectal cancer. https://pubmed.ncbi.nlm.nih.gov/40388545/ 23.       Dasari, A. et al. Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. The Lancet 402, 41–53 (2023). https://pubmed.ncbi.nlm.nih.gov/37331369/ 24.       Strickler, J. H. et al. Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study. Lancet Oncol. 24, 496–508 (2023). https://pubmed.ncbi.nlm.nih.gov/37142372/ 25.       Sauer, R. et al. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N. Engl. J. Med. 351, 1731–1740 (2004). https://pubmed.ncbi.nlm.nih.gov/15496622/ 26.       Cercek, A. et al. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer. JAMA Oncol. 4, e180071 (2018). https://pubmed.ncbi.nlm.nih.gov/29566109/ 27.       Garcia-Aguilar, J. et al. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy. J. Clin. Oncol. 40, 2546–2556 (2022). https://pubmed.ncbi.nlm.nih.gov/35483010/ 28.       Schrag, D. et al. Preoperative Treatment of Locally Advanced Rectal Cancer. N. Engl. J. Med. 389, 322–334 (2023). https://pubmed.ncbi.nlm.nih.gov/37272534/ 29.       Kunkler, I. H., Williams, L. J., Jack, W. J. L., Cameron, D. A. & Dixon, J. M. Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer. N. Engl. J. Med. 388, 585–594 (2023). https://pubmed.ncbi.nlm.nih.gov/36791159/ 30.       Jacobsen, R. L., Macpherson, C. F., Pflugeisen, B. M. & Johnson, R. H. Care Experience, by Site of Care, for Adolescents and Young Adults With Cancer. JCO Oncol. Pract. (2021) doi:10.1200/OP.20.00840. https://pubmed.ncbi.nlm.nih.gov/33566700/ 31.       Ruddy, K. J. et al. Prospective Study of Fertility Concerns and Preservation Strategies in Young Women With Breast Cancer. J. Clin. Oncol. (2014) doi:10.1200/JCO.2013.52.8877. https://pubmed.ncbi.nlm.nih.gov/24567428/ 32.       Su, H. I. et al. Fertility Preservation in People With Cancer: ASCO Guideline Update. J. Clin. Oncol. 43, 1488–1515 (2025). https://pubmed.ncbi.nlm.nih.gov/40106739/ 33.       Smith, K. L., Gracia, C., Sokalska, A. & Moore, H. Advances in Fertility Preservation for Young Women With Cancer. Am. Soc. Clin. Oncol. Educ. Book 27–37 (2018) doi:10.1200/EDBK_208301. https://pubmed.ncbi.nlm.nih.gov/30231357/ 34.       Blumenfeld, Z. How to Preserve Fertility in Young Women Exposed to Chemotherapy? The Role of GnRH Agonist Cotreatment in Addition to Cryopreservation of Embrya, Oocytes, or Ovaries. The Oncologist 12, 1044–1054 (2007). 35.       Bhagavath, B. The current and future state of surgery in reproductive endocrinology. Curr. Opin. Obstet. Gynecol. 34, 164 (2022). 36.       Ribeiro, R. et al. Uterine transposition: technique and a case report. Fertil. Steril. 108, 320-324.e1 (2017). 37.       Yazdani, A., Sweterlitsch, K. M., Kim, H., Flyckt, R. L. & Christianson, M. S. Surgical Innovations to Protect Fertility from Oncologic Pelvic Radiation Therapy: Ovarian Transposition and Uterine Fixation. J. Clin. Med. 13, 5577 (2024). 38.       Holowatyj, A. N., Eng, C. & Lewis, M. A. Incorporating Reproductive Health in the Clinical Management of Early-Onset Colorectal Cancer. JCO Oncol. Pract. 18, 169–172 (2022). ***Behind the Knife Colorectal Surgery Oral Board Audio Review: https://app.behindtheknife.org/course-details/colorectal-surgery-oral-board-audio-review Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

The EC Show: The Headaches of Producing Live Content Enasia Colon off to FSU MLB All Star & more.Live from the beautiful chaos of South Florida, this week's episode is a cinematic struggle bus—with your favorite host EJ Colón wrapping up his last week in the Sunshine State before marching off to Florida State University with snacks, swag, and questionable sleep hygiene.

In this episode, Therese Markow and Dr. Peter Liang discuss the rise in colorectal cancer among younger people, those below the age of 50. While colorectal cancer is a slow-growing cancer, it is still the third most common cancer for both men and women, and the second leading cause of cancer death in the United States. Due to the trend of decreasing age in colorectal cancer patients, screening guidelines have been lowered to 45, but can be done earlier as needed, based on risk factors. Dr. Liang emphasizes the importance of screening, diet, exercise, and awareness of family history in preventing and detecting colorectal cancer early.     Key Takeaways: Colorectal cancer is the third most common cause of cancer in both men and women. It is the second leading cause of cancer death behind lung cancer. Early-onset colorectal cancer is traditionally defined as occurring in people under age 50. However, there is a rise in people in their 40s, though some (though they are a minority) are in their 20s or 30s. Colorectal cancer is unique due to the number of different tests available for screening for prevention. Colorectal cancer is a slow-growing cancer. A single polyp can sometimes take 10-20 years to develop into cancer. There is no evidence correlating constipation with colorectal cancer. If people want to do juices or fasts or colonics, that is fine, but there is no medical need to do it. If you have symptoms that are concerning, tell your doctor. Sometimes you do need to advocate for yourself to get additional testing.   "Any test that is not a colonoscopy and is abnormal does need to be followed by a colonoscopy. How we prevent Colorectal cancer is by going in with the colonoscopy, removing polyps (which can turn into cancer), or by finding the cancer early, so that your prognosis is much better." —  Dr. Peter Liang   Connect with Dr. Peter Liang: Professional Bio: https://med.nyu.edu/faculty/peter-s-liang  Website: https://med.nyu.edu/research/liang-lab/    Connect with Therese: Website: www.criticallyspeaking.net Threads: @critically_speaking Email: theresemarkow@criticallyspeaking.net     Audio production by Turnkey Podcast Productions. You're the expert. Your podcast will prove it.  

Send us a textStruggling with constipation, diarrhea, or hemorrhoids—and not sure why? In this gut health deep dive, Jessie Wong is joined by colorectal surgeon and Constipation Nation author Dr. Carmen Fong to unpack the real reasons your IBS symptoms might still be flaring up, even when you're doing “everything right.”In This Episode, You'll Learn:✔️ What GLP-1 meds are really doing to your digestion✔️ Constipation fixes that actually work (food, fibre, hydration & more)✔️ Which gut health trends to skip (microbiome tests, detoxes, etc.)Timestamps:[00:00] Intro – Meet Dr. Carmen Fong and today's gut health topics[03:41] GLP-1 medications & gut side effects (constipation, diarrhoea)[11:06] Breaking stigma: why talking about poop matters[19:15] Top tips to relieve constipation without meds[21:18] What to know about haemorrhoids, fissures & rectal health[33:47] Debunking myths: gut microbiome tests, food sensitivity tests & probiotics[53:04] How to properly follow (and not fear) the low FODMAP diet[59:51] Colon cleanses, detoxes & intermittent fasting: helpful or harmful?[01:07:01] Intuitive eating & how restriction leads to food obsessionResources Mentioned:Episode 15Episode 6Episode 17www.carmenfong.comInstagram: Dr. Carmen FongGet Dr. Carmen Fong's book https://carmenfong.com/best-gut-health-book ⭐ Love this episode? Leave us a 5-star review! It helps us reach more people who need IBS support. As a special bonus, I want to give you FREE access to my signature IBS Course. • Leave a review of this podcast • Email a screenshot of your review to info@ibsdietitian.comGet our help:

Healthcare just got personal for A Shot In The Arm Podcast's Ben Plumley, who brings his offbeat insights & humor to a surprise advanced colon cancer diagnosis. Join him on an odyssey around cancer treatment and the vagaries of the Californian health system. New episodes weekly… hopefully. https://www.mycrohnsandcolitisteam.com/ https://www.cancer.gov/types/colorectal https://www.cancer.org/cancer/types/colon-rectal-cancer.html

Ben has a routine colonoscopy and comes out with an unexpected diagnosis – an ulcerated mass in his ascending colon. The gastroenterologist gives him his first tattoo ever, which is sadly visible only to the surgeon who will remove it. Ben has been living with Crohn's Disease since he was a teenager, so the news of an intestinal polyp turning cancerous is not shocking. An easy snip-snip excision by the surgeon, and all will be back to normal…. Or will it? 00:00 Introduction & Diagnosis 01:11 Personal Reflections and Stigma 02:58 Living with Crohn's Disease 05:07 The Experience of Having a Colonoscopy 09:07 Post-Procedure and Results 11:57 Facing Mortality and Future Plans 16:25 A Personal Incident 19:14 Conclusion & Sign Off https://www.mycrohnsandcolitisteam.com/ https://www.cancer.gov/types/colorectal https://www.cancer.org/cancer/types/colon-rectal-cancer.html

A quick trip to the surgeon reveals that all is not as it seems, and Ben's colon cancer journey takes a sharp turn almost as immediately as it starts. Multiple tumors during a surgery initially meant to remove a single cancerous mass lead to a diagnosis of metastasized colorectal cancer. And the expensive nuclear diagnosis machine shorts – in much the same way Ben's Father's brand new (at the time) Vauxhall Victor broke down on a Sunday afternoon drive. A potential podcast subject that Ben dismissed years ago as not being interesting enough (Italian data on a barrage of combination chemotherapy) reappears as the best first-line treatment option for Ben in 2025. The episode concludes with insights from Ben's oncologist and preparation for the rigorous chemotherapy regimen ahead: Chemotherapy – it's a full-time job. 00:00 Introduction: The Vauxhall Victor Story 02:11 Unexpected Medical News 04:12 Understanding the Diagnosis 06:45 The PET Scan Incident 11:04 Meeting the Oncologist 15:15 Preparing for Chemotherapy 16:58 Conclusion: The Journey Ahead https://www.mycrohnsandcolitisteam.com/ https://www.cancer.gov/types/colorectal https://www.cancer.org/cancer/types/colon-rectal-cancer.html

Un pólipo es una parte de tejido adicional que crece dentro de su cuerpo.

Feeling bloated, sluggish, or stuck on the scale? Your colon may be backed up with years of waste. Learn natural, safe ways to reboot your digestion — and your life.What if your heartburn isn't caused by too much acid — but too little? Find out the surprising truth and how to fix it without lifelong meds. #ColonHealth #ToxicGut #PreventColonCancer #WellnessWarning #LivingTheWellnessLife #ListenToYourGut #ColonCleanse #AcidRefluxRelief #HeartburnTruth #LivingTheWellnessLife #RefluxRemedy #GutHealing #HolisticHealth #NoMorePPI

Bobby Bones and Matt Cassel talk about the heatwave and how poorly swimming headphones work. Did Tom Brady say no to Aaron Rodgers and Sam Darnold with the Raiders? Brady won a fan competition and Bobby wonders if Tom's level of competitiveness is unhealthy. Travis Hunter signs his rookie deal with the Jaguars. Matt explains what will be expected of Hunter in camp. Super Bowl Champ Willie Colon comments on Rodgers saying this could be his last year in the NFL. Colon has played after an achilles injury as well and gives his thoughts on how Rodgers will play with the Steelers. Bobby asks about Willie's playing days at Hofstra and his transition to the NFL. Willie reveals the strongest and fastest players he ever played against. Willie takes us inside the very real rivalry between the Steelers and the Ravens. "Which age should a grown man stop doing this?" Bobby and Matt explain things like wearing jerseys, painting your face, bringing a glove to a game, or asking for an autograph. Bobby and Matt both discuss dealing with adults seeking autographs just to sell them. Is it ever okay to cry after your team loses? Matt shares a personal experience of why he once cried on the field. Lots to Say with Bobby Bones and Matt Cassel is part of the NFL Podcast Network See omnystudio.com/listener for privacy information.

You have a patient with complicated diverticulitis s/p IR drain with colo-cutaneous fistula and colo-vaginal fistula. They are scheduled for surgery. How will you do it? What is the role for hand assist? How can hand assist help? Tune in to find out! Join Drs. Peter Marcello, Jonathan Abelson, and Tess Aulet as they discuss high yield papers discussing hand assist laparoscopy in Colon and Rectal surgery.  Learning Objectives 1. Describe the technical considerations and how to do hand assist laparoscopic surgery (HALS) 2. Discuss the indications for use of HALS 3. Review literature supporting use of HALS   References: Marcello PW, Fleshman JW, Milsom JW, Read TE, Arnell TD, Birnbaum EH, Feingold DL, Lee SW, Mutch MG, Sonoda T, Yan Y, Whelan RL. Hand-assisted laparoscopic vs. laparoscopic colorectal surgery: a multicenter, prospective, randomized trial. Dis Colon Rectum. 2008 Jun;51(6):818-26; discussion 826-8. doi: 10.1007/s10350-008-9269-5. Epub 2008 Apr 17. PMID: 18418653. https://pubmed.ncbi.nlm.nih.gov/18418653/ Jacobs C, Read TE. "Peek port": avoiding conversion during laparoscopic colectomy-an update. Surg Endosc. 2020 Sep;34(9):3944-3948. doi: 10.1007/s00464-019-07165-3. Epub 2019 Oct 4. PMID: 31586252. https://pubmed.ncbi.nlm.nih.gov/31586252/ Heneghan HM, Martin ST, Kiran RP, Khoury W, Stocchi L, Remzi FH, Vogel JD. Laparoscopic colorectal surgery for obese patients: decreased conversions with the hand-assisted technique. J Gastrointest Surg. 2013 Mar;17(3):548-54. doi: 10.1007/s11605-012-2089-x. Epub 2012 Nov 27. PMID: 23188222. https://pubmed.ncbi.nlm.nih.gov/23188222/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://app.behindtheknife.org/listen

Jerry and Willie Colon are in for B&G. As we sit here on June 17, the Knicks don't seem any closer to signing a head coach. Willie was not happy with the Knicks firing Thibs. C-Lo returns for his final update of the day and starts with the Yankees getting shutout again, 1-0. Adam Schein had a little hyperbole for the Rafael Devers trade. The Moment of The Day: Willie Colon had a bathroom emergency at 4am in NYC. In the final segment of the show, we cleaned up the calls on the Knicks and Yankees.

The Alan Cox Show

Hey, Heal Squad! You may know her from viral videos and billion-view challenges, but today, Rebecca Zamolo is sharing the story behind the screen—one marked by pain, resilience, and radical honesty. In Part 1 of our raw and inspiring conversation, Rebecca opens up about her battle with chronic illness, the life-altering decision to remove her colon, and how that journey impacted her self-worth, identity, and relationships. She walks us through the emotional toll of IVF, the heartbreak of miscarriage, and what it was like to navigate it all while being in the public eye. We explore how she rebuilt her strength (physically and emotionally) and why she chose to share these deeply personal moments with her audience. Whether you're navigating a health crisis, infertility, or just need a reminder that healing is possible, Rebecca's story will move you and empower you to keep going. HEALERS & HEAL-LINERS:  Chronic illness doesn't care about your plans. Rebecca was at the top of her career when her health crashed. Her body forced her to stop, reassess, and choose healing—even when it meant removing her colon. You can be grateful and grieving at the same time. Rebecca shares the emotional rollercoaster of IVF and miscarriage, revealing how it's possible to feel joy for others while holding heartbreak for yourself. Silence breeds shame. She explains how speaking publicly about her miscarriage helped her release shame and allowed others to feel seen in their own stories. HEAL SQUAD SOCIALS IG: https://www.instagram.com/healsquad/ TikTok: https://www.tiktok.com/@healsquadxmaria HEAL SQUAD RESOURCES: Heal Squad Website:https://www.healsquad.com/ Heal Squad x Patreon: https://www.patreon.com/HealSquad/membership Maria Menounos Website: https://www.mariamenounos.com My Curated Macy's Page: Shop My Macy's Storefront Prenuvo: Prenuvo.com/MARIA for $300 off Delete Me: https://bit.ly/43rkHwi   code: SQUAD EMR-Tek Red Light: https://emr-tek.com/discount/Maria30 for 30% off Airbnb: https://www.airbnb.com/  Join the In-Person Heal Retreat: https://www.canyonranch.com/stay/events/heal-retreat-with-maria-menounos/?location=lenox  GUEST RESOURCES: Instagram: https://www.instagram.com/rebeccazamolo/  Website: https://rebeccazamolo.com/?srsltid=AfmBOoqM1LIbAfHR4GpfLcMXnKg65pIBLr4E9s8z5IAzG694LQYHjLBV  Fertility Supplements: https://www.walmart.com/search?q=Molo&fbclid=PAZXh0bgNhZW0CMTEAAafYuX0wThrhkfwSxkAmv8gk3yRAIeVGoByI_OTLt270rS4dm29bcxpOmr2eww_aem_YhZQ-lferJzbdQmDKwAHvg  Ostomy Secrets: https://www.ostomysecrets.com/  ABOUT MARIA MENOUNOS: Emmy Award-winning journalist, TV personality, actress, 2x NYT best-selling author, former pro-wrestler and brain tumor survivor, Maria Menounos' passion is to see others heal and to get better in all areas of life. ABOUT HEAL SQUAD x MARIA MENOUNOS: A daily digital talk-show that brings you the world's leading healers, experts, and celebrities to share groundbreaking secrets and tips to getting better in all areas of life. DISCLAIMER: This Podcast and all related content (published or distributed by or on behalf of Maria Menounos or http://Mariamenounos.com and http://healsquad.com) is for informational purposes only and may include information that is general in nature and that is not specific to you. Any information or opinions provided by guest experts or hosts featured within website or on Company's Podcast are their own; not those of Maria Menounos or the Company. Accordingly, Maria Menounos and the Company cannot be responsible for any results or consequences or actions you may take based on such information or opinions. This podcast is presented for exploratory purposes only. Published content is not intended to be used for preventing, diagnosing, or treating a specific illness. If you have, or suspect you may have, a health-care emergency, please contact a qualified health care professional for treatment.

Do you really need a colonoscopy? Whether you're hitting your 40s and facing pressure to schedule your first scope, or you're curious if non-invasive options like Cologuard are good enough, we've got you covered in this week's episode. We break down the pros and cons of each screening method, highlight some major concerns, and unpack the surprising data on the rise of colorectal cancer—especially in younger populations. In this episode, we also dig into how dysbiosis, inflammation, and diet play a role in colon cancer development—and more importantly, how you can be proactive with prevention. From sulforaphane to resistant starch, you'll walk away with tangible tools to love on your colon and support optimal detox and gut health. Also in this episode:  Colon cancer stats Why are we seeing an increase in younger adults?  Risk factors for colon cancer Bacon in the Oven (Plus Bacon Health Benefits and Myths) - YouTube Inflammazyme (for polyps) Colonoscopy vs. Cologuard GI Map Stool Test Occult blood Secretory IgA  Calprotectin Microbiome makeup Beta-glucoronidase SCFAs Colonoscopy Prep Pre and Post Surgery Protocol Bone Broth Gelatin (not red or purple!) Castor oil Buffered Vitamin C Mag Citrate Lily of The Desert Aloe Vera Juice Whole Leaf Electrolyte Limeade Post Procedure Support GI Lining Support Targeted Strength Probiotic Rebuild Spectrum Probiotic  Colon Cancer Prevention Reducing Toxicity while Grilling Fiber Rich Foods Phytofiber Polyphenols Lemon Turmeric Shooter Healthy Fats Fermented Foods The seed oil colon cancer link Supplement Support Vitamin D Balanced Blend Inflammazyme EPA DHA Extra Cellular Antiox Restore Baseline Probiotic Probiotic Challenge Rebuild Spectrum Probiotic Women's Flora Probiotic GI Lining Support GI Immune Builder Multidefense   This episode is sponsored by: This episode is sponsored by Wild Foods, a company that puts quality, sustainability, and health first in all of their products. They have everything from coffee to turmeric to medicinal mushrooms, and every single product is painstakingly sourced from small farms around the globe. They take their mission seriously to fix the broken food system, and believe real food is medicine. They've partnered with us to give you guys an exclusive discount, so use the code ALIMILLERRD for 12% off your order at WildFoods.co!